Johnson & Johnson announces that its affiliate Janssen Pharmaceutica NV (Janssen) has launched a new collaboration with Harvard Medical School to improve the health of communities most affected by drug-resistant tuberculosis (DR-TB).
A new study published in Nature Biotechnology Collaboration with University of British Columbia and BetaLogics, a division within Janssen Research & Development, LLC, shows promising new protocol for creating insulin-producing cells in about six weeks, far quicker than the four months it took using previous methods marking great progress in the treatment of Type 1 diabetes.
September is AFib Awareness Month and NASCAR® Legend Michael Waltrip is teaming up with Janssen, a Johnson & Johnson company, to help raise awareness about atrial fibrillation. In a guest post for the JNJ Blog, Michael opens up about his mother’s experience with AFib and stroke and shares information on how you can show your support.
Welcome to the Johnson & Johnson corporate website home page. The stories on this page are inspired by our commitment to caring for the health and well-being of people around the world.